MedTrace Logo

Vancomycin Dosage Adjustment for MRSA Infections

NCT03412500 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2018-01-26

No results posted yet for this study

Summary

An open-label randomized controlled trial to compare two vancomycin dosage adjustment methods

Conditions

  • Methicillin-Resistant Staphylococcus Aureus

Interventions

DRUG

Vancomycin equation-based method

Vancomycin dosage will be adjusted according to the equation-based method

DRUG

Vancomycin trough concentration method

Vancomycin dosage will be adjusted according to the trough concentration method

Sponsors & Collaborators

  • Pinyo Rattanaumpawan

    lead OTHER

Principal Investigators

  • pinyo rattanaumpawan, md · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03412500 on ClinicalTrials.gov